Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Trials
.
2022 Feb 10;23(1):134.
doi: 10.1186/s13063-022-06079-1.
Authors
Christopher Kai Shun Leung
1
2
3
,
Seraph Tianmin Ren
4
,
Poemen Pui Man Chan
5
4
,
Kelvin Ho Nam Wan
5
4
,
Aziz Ka Wai Kam
4
,
Gilda Wing Ki Lai
6
,
Vivian Sheung Man Chiu
6
,
Match Wai Lun Ko
7
,
Cedric Ka Fai Yiu
8
,
Marco Chak Yan Yu
9
Affiliations
1
Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
[email protected]
.
2
Hong Kong Eye Hospital, Hong Kong, People's Republic of China.
[email protected]
.
3
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
[email protected]
.
4
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
5
Hong Kong Eye Hospital, Hong Kong, People's Republic of China.
6
Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
7
Department of Mechanical Engineering, University of Hong Kong, Hong Kong, People's Republic of China.
8
Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, People's Republic of China.
9
Singapore Eye Research Institute, Singapore, Singapore.
PMID:
35144657
PMCID:
PMC8832638
DOI:
10.1186/s13063-022-06079-1
No abstract available
Publication types
Published Erratum